• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌患者中的造血生长因子。

Hematopoietic growth factors in colorectal cancer patients.

作者信息

Mroczko Barbara, Szmitkowski Maciej, Okulczyk Bogna

机构信息

Department of Biochemical Diagnostics, Medical Academy, Białystok, Poland.

出版信息

Clin Chem Lab Med. 2003 May;41(5):646-51. doi: 10.1515/CCLM.2003.098.

DOI:10.1515/CCLM.2003.098
PMID:12812262
Abstract

Hematopoietic growth factors (HGFs) are involved in the regulation of growth and spread of cancer. Therefore, in the present study, we have investigated in colorectal cancer patients the serum levels of selected HGFs, such as stem cell factor (SCF), interleukin 3 (IL-3), granulocyte-macrophage-colony stimulating factor (GM-CSF), and M-CSF in relation to controls and to the classical tumor markers, such as carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9) in colorectal cancer. Additionally, we have compared the serum levels of cytokines with tumor site and stage and other clinical characteristics such as age and sex. We also defined the receiver-operating characteristics (ROC) curve for HGFs and classical tumor markers. The tested cytokines were measured in 70 patients with colorectal cancer and in 40 healthy subjects. HGFs were determined using enzyme-linked immunosorbent assay (ELISA). CEA and CA 19-9 were measured by microparticle enzyme immunoassay. There were significant differences in the levels of circulating SCF, IL-3, M-CSF, GM-CSF, and CEA and CA 19-9 in the colorectal cancer patients compared to the control group. The levels of M-CSF and CEA were significantly higher in patients with a more advanced tumor stage. The significant positive correlation was observed between the CEA and CA 19-9 concentrations. The M-CSF serum levels correlated positively with the tested tumor markers. The M-CSF area under the ROC curve was the largest. These results suggest that M-CSF is, among the tested HGFs, the best candidate for a colorectal cancer tumor marker.

摘要

造血生长因子(HGFs)参与癌症的生长和扩散调节。因此,在本研究中,我们调查了结肠癌患者中所选HGFs的血清水平,如干细胞因子(SCF)、白细胞介素3(IL-3)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)和M-CSF,并与对照组以及结肠癌中的经典肿瘤标志物,如癌胚抗原(CEA)和糖类抗原19-9(CA 19-9)进行比较。此外,我们还比较了细胞因子的血清水平与肿瘤部位、分期以及年龄和性别等其他临床特征。我们还定义了HGFs和经典肿瘤标志物的受试者操作特征(ROC)曲线。在70例结肠癌患者和40例健康受试者中检测了所测试的细胞因子。使用酶联免疫吸附测定(ELISA)法测定HGFs。通过微粒酶免疫测定法测量CEA和CA 19-9。与对照组相比,结肠癌患者循环中的SCF、IL-3、M-CSF、GM-CSF以及CEA和CA 19-9水平存在显著差异。肿瘤分期较晚的患者中M-CSF和CEA水平显著更高。CEA和CA 19-9浓度之间存在显著正相关。M-CSF血清水平与所测试的肿瘤标志物呈正相关。ROC曲线下M-CSF的面积最大。这些结果表明,在所测试的HGFs中,M-CSF是结肠癌肿瘤标志物的最佳候选者。

相似文献

1
Hematopoietic growth factors in colorectal cancer patients.结直肠癌患者中的造血生长因子。
Clin Chem Lab Med. 2003 May;41(5):646-51. doi: 10.1515/CCLM.2003.098.
2
Hematopoietic cytokines in the sera of patients with pancreatic cancer.胰腺癌患者血清中的造血细胞因子。
Clin Chem Lab Med. 2005;43(2):146-50. doi: 10.1515/CCLM.2005.024.
3
Stem cell factor and macrophage-colony stimulating factor in patients with pancreatic cancer.胰腺癌患者体内的干细胞因子和巨噬细胞集落刺激因子
Clin Chem Lab Med. 2004 Mar;42(3):256-60. doi: 10.1515/CCLM.2004.047.
4
Pretreatment serum levels of hematopoietic cytokines in patients with colorectal adenomas and cancer.结直肠腺瘤和癌症患者造血细胞因子的预处理血清水平。
Int J Colorectal Dis. 2007 Jan;22(1):33-8. doi: 10.1007/s00384-006-0099-4. Epub 2006 Mar 7.
5
Role of the hematopoietic cytokines SCF, IL-3, GM-CSF and M-CSF in the diagnosis of pancreatic and ampullary cancer.造血细胞因子 SCF、IL-3、GM-CSF 和 M-CSF 在胰腺和壶腹癌诊断中的作用。
Int J Biol Markers. 2012 Oct 8;27(3):e186-94. doi: 10.5301/JBM.2012.9348.
6
Granulocyte-colony stimulating factor (G-CSF) and macrophagecolony stimulating factor (M-CSF) in colorectal cancer patients.结直肠癌患者体内的粒细胞集落刺激因子(G-CSF)和巨噬细胞集落刺激因子(M-CSF)
Clin Chem Lab Med. 2002 Apr;40(4):351-5. doi: 10.1515/CCLM.2002.056.
7
Stem cell factor and granulocyte-macrophage-colony stimulating factor as candidates for tumour markers for non-small-cell lung cancer.干细胞因子和粒细胞-巨噬细胞集落刺激因子作为非小细胞肺癌肿瘤标志物的候选物。
Clin Chem Lab Med. 1999 Oct;37(10):959-62. doi: 10.1515/CCLM.1999.141.
8
Stem cell factor (SCF) and interleukin 3 (IL-3) in the sera of patients with colorectal cancer.结直肠癌患者血清中的干细胞因子(SCF)和白细胞介素3(IL-3)
Dig Dis Sci. 2005 Jun;50(6):1019-24. doi: 10.1007/s10620-005-2697-3.
9
[The plasma levels and diagnostic utility of selected hematopoietic growth factors (HGFs) in breast cancer patients].[乳腺癌患者中特定造血生长因子(HGFs)的血浆水平及诊断效用]
Przegl Lek. 2010;67(12):1314-8.
10
[Selected hematopoietic cytokines in patients with colorectal cancer].[结直肠癌患者中选定的造血细胞因子]
Pol Merkur Lekarski. 2003 Nov;15(89):416-9.

引用本文的文献

1
Proliferating macrophages in human tumours show characteristics of monocytes responding to myelopoietic growth factors.人类肿瘤中的增殖巨噬细胞表现出对造血生长因子有反应的单核细胞的特征。
Front Immunol. 2024 Jun 5;15:1412076. doi: 10.3389/fimmu.2024.1412076. eCollection 2024.
2
MicroRNA-34 and gastrointestinal cancers: a player with big functions.微小RNA-34与胃肠道癌症:一个功能强大的参与者。
Cancer Cell Int. 2024 May 9;24(1):163. doi: 10.1186/s12935-024-03338-w.
3
CSF-1R in Cancer: More than a Myeloid Cell Receptor.癌症中的集落刺激因子1受体:不仅仅是一种髓样细胞受体。
Cancers (Basel). 2024 Jan 9;16(2):282. doi: 10.3390/cancers16020282.
4
M-MDSC generation from mouse bone marrow with IL-3 reveals high expression and functional activity of arginase 1.IL-3 诱导的小鼠骨髓来源 M-MDSC 具有高表达和高功能活性的精氨酸酶 1。
Front Immunol. 2023 May 19;14:1130600. doi: 10.3389/fimmu.2023.1130600. eCollection 2023.
5
Old and New Blood Markers in Human Colorectal Cancer.人结直肠癌的新旧血液标志物。
Int J Mol Sci. 2022 Oct 26;23(21):12968. doi: 10.3390/ijms232112968.
6
Self-Renewal of Macrophages: Tumor-Released Factors and Signaling Pathways.巨噬细胞的自我更新:肿瘤释放因子与信号通路
Biomedicines. 2022 Oct 26;10(11):2709. doi: 10.3390/biomedicines10112709.
7
Circulating Biomarkers of Colorectal Cancer (CRC)-Their Utility in Diagnosis and Prognosis.结直肠癌(CRC)的循环生物标志物——它们在诊断和预后中的应用
J Clin Med. 2021 May 28;10(11):2391. doi: 10.3390/jcm10112391.
8
Diagnostic performances of leucine-rich α-2-glycoprotein 1 and stem cell factor for diagnosis and follow-up of colorectal cancer.富含亮氨酸的α-2-糖蛋白1和干细胞因子在结直肠癌诊断及随访中的诊断效能
J Genet Eng Biotechnol. 2021 Jan 25;19(1):17. doi: 10.1186/s43141-021-00116-3.
9
Biochemical Markers of Colorectal Cancer - Present and Future.结直肠癌的生化标志物——现状与未来
Cancer Manag Res. 2020 Jun 22;12:4789-4797. doi: 10.2147/CMAR.S253369. eCollection 2020.
10
Characterization of a p53/miR-34a/CSF1R/STAT3 Feedback Loop in Colorectal Cancer.结直肠癌中 p53/miR-34a/CSF1R/STAT3 反馈回路的特征。
Cell Mol Gastroenterol Hepatol. 2020;10(2):391-418. doi: 10.1016/j.jcmgh.2020.04.002. Epub 2020 Apr 15.